Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis

被引：0
|
作者：
Mueller, M. [1 ]
Brand, A. [1 ]
Mattig, I. [1 ]
Spethmann, S. [1 ]
Messroghli, D. [1 ]
Hahn, K. [2 ]
Landmesser, U. [1 ]
Heidecker, B. [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Cardiol Angiol & Intens Care Med, Deutsch Herzzentrum Charite, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Neurol & Expt Neurol, Berlin, Germany
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2093
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 37 条
  • [31] Prognostic Stage Groups Established by AJCC Staging System 8th Edition Does Not Significantly Improve Discrimination Over Classic TNM Staging in Early Stage Breast Cancer Treated With Breast Conservative Therapy
    Chen, S.
    Wang, S.
    Tang, Y.
    Yu, Z. H.
    Jin, J.
    Liu, Y. P.
    Liu, X. F.
    Song, Y. W.
    Fang, H.
    Li, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E7 - E7
  • [32] Application of a Prognostic Stratification System for High-Risk Prostate Cancer to Patients Treated with Radiation Therapy: Implications for Treatment Optimization
    Foster, B.
    Jackson, W. C.
    Foster, C. C.
    Dess, R. T.
    Abu-Isa, E. I.
    McLaughlin, P. W.
    Merrick, G. S.
    Hearn, J. W. D.
    Spratt, D. E.
    Liauw, S.
    Hamstra, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E109 - E110
  • [33] Prognostic significance of molecular staging and minimal residual disease in high-risk diffuse large B-cell lymphoma treated with autologous stem cell transplantation (Mega-CHOEP)
    Pott, C
    Mueller-Albrecht, M
    Jung, W
    Neumann, S
    Truemper, L
    Schmitz, N
    Glass, B
    Kneba, M
    ANNALS OF ONCOLOGY, 2005, 16 : 185 - 185
  • [34] Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response
    Breccia, Massimo
    Loglisci, Giuseppina
    Cannella, Laura
    Finsinger, Paola
    Mancini, Marco
    Serrao, Alessandra
    Santopietro, Michelina
    Salaroli, Adriano
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 985 - 986
  • [35] Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials
    Zoehrlaut, Linda Katharina
    Karthaus, Meinolf
    Vehling-Kaiser, Ursula
    von Kunhardt, Lukas
    Stintzing, Sebastian
    Heinemann, Volker
    von Einem, Jobst C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (09) : 348 - 360
  • [36] Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related Death
    Moreau, Philippe
    Cavo, Michele
    Sonneveld, Pieter
    Rosinol, Laura
    Attal, Michel
    Pezzi, Annalisa
    Goldschmidt, Hartmut
    Lahuerta, Juan Jose
    Marit, Gerald
    Palumbo, Antonio
    van der Holt, Bronno
    Blade, Joan
    Petrucci, Maria Teresa
    Neben, Kai
    san Miguel, Jesus
    Patriarca, Francesca
    Lokhorst, Henk
    Zamagni, Elena
    Hulin, Cyrille
    Gutierrez, Norma
    Facon, Thierry
    Caillot, Denis
    Benboubker, Lotfi
    Harousseau, Jean-Luc
    Leleu, Xavier
    Avet-Loiseau, Herve
    Mary, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (20) : 2173 - +
  • [37] Prognostic value of baseline FDG PET parameters in high risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy including early systemic central nervous system prophylaxis in a prospective Nordic multicentre study
    Stokke, C.
    Fiskvik, I.
    Mikalsen, L.
    Loimaala, A.
    Schildt, J.
    Leppa, S.
    Holte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S485 - S486
1234